Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCHW) Operating Expenses (2022 - 2025)

Historic Operating Expenses for Envoy Medical (COCHW) over the last 4 years, with Q3 2025 value amounting to $5.8 million.

  • Envoy Medical's Operating Expenses rose 1435.96% to $5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.6 million, marking a year-over-year decrease of 491.5%. This contributed to the annual value of $19.5 million for FY2024, which is 431.59% up from last year.
  • Latest data reveals that Envoy Medical reported Operating Expenses of $5.8 million as of Q3 2025, which was up 1435.96% from $5.1 million recorded in Q2 2025.
  • Envoy Medical's Operating Expenses' 5-year high stood at $6.8 million during Q4 2023, with a 5-year trough of $901356.0 in Q2 2022.
  • For the 4-year period, Envoy Medical's Operating Expenses averaged around $4.1 million, with its median value being $4.6 million (2024).
  • Per our database at Business Quant, Envoy Medical's Operating Expenses skyrocketed by 40401.84% in 2023 and then plummeted by 3266.35% in 2024.
  • Envoy Medical's Operating Expenses (Quarter) stood at $2.9 million in 2022, then surged by 133.01% to $6.8 million in 2023, then tumbled by 32.66% to $4.6 million in 2024, then rose by 25.25% to $5.8 million in 2025.
  • Its last three reported values are $5.8 million in Q3 2025, $5.1 million for Q2 2025, and $5.2 million during Q1 2025.